Proposed Information Collection Activity; Comment Request, 12742 [2011-5181]
Download as PDF
<![CDATA[
12742
Federal Register / Vol. 76, No. 45 / Tuesday, March 8, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Family Violence Prevention and
Services: Grants to State; Native
American Tribes and Alaskan Native
Villages, and State Domestic Violence
Coalitions.
OMB No.: 0970–0280.
Description: The Family Violence
Prevention and Services Act (FVPSA),
42 U.S.C. 10401 et seq., authorizes the
Department of Health and Human
Services to award grants to States,
Tribes—and Tribal Organizations, and
State Domestic Violence Coalitions for
family violence prevention and
intervention activities. The proposed
information collection activities will be
used to make grant award decisions and
to monitor grant performance.
Respondents
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
srobinson on DSKHWCL6B1PROD with NOTICES
State Grant Application ....................................................................................
Tribal Grant Application ...................................................................................
State Domestic Violence Coalition Application ................................................
State FVPSA Grant Performance Progress Report ........................................
Tribal FVPSA Grant Performance Progress Report ........................................
Estimated Total Annual Burden
Hours: 4,620
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
VerDate Mar<15>2010
19:12 Mar 07, 2011
Jkt 223001
53
200
56
53
200
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011–5181 Filed 3–7–11; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–D–0457]
Guidance for Industry and Food and
Drug Administration Staff; Clinical
Investigations of Devices Indicated for
the Treatment of Urinary Incontinence;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the guidance entitled
‘‘Clinical Investigations of Devices
Indicated for the Treatment of Urinary
Incontinence.’’ This guidance document
describes FDA’s recommendations for
clinical investigations of medical
devices indicated for the treatment of
urinary incontinence.
DATES: Submit either electronic or
written comments on this guidance at
any time. General comments on Agency
guidance documents are welcome at any
time.
ADDRESSES: Submit written requests for
single copies of the guidance document
entitled ‘‘Clinical Investigations of
Devices Indicated for the Treatment of
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Number of responses per
respondent
Average
burden hours
per response
1
1
1
1
1
10
5
10
10
10
Total burden
hours
530
1,000
560
530
2,000
Urinary Incontinence ’’ to the Division
of Small Manufacturers, International,
and Consumer Assistance, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 4613,
Silver Spring, MD 20993–0002. Send
one self-addressed adhesive label to
assist that office in processing your
request, or fax your request to 301–847–
8149. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the guidance.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Identify comments with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: John
Baxley, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. G210, Silver Spring,
MD 20993–0002, 301–796–6549.
SUPPLEMENTARY INFORMATION:
I. Background
Urinary incontinence is defined as the
involuntary loss of urine. This guidance
is intended to assist device
manufacturers who plan to conduct
clinical investigations of devices
intended to treat urinary incontinence
in support of premarket approval (PMA)
applications or premarket notification
(510(k)) submissions. The guidance
describes FDA’s recommendations for
human clinical trials that involve the
use of any type of urinary incontinence
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 76, Number 45 (Tuesday, March 8, 2011)]
[Notices]
[Page 12742]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5181]
[[Page 12742]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Proposed Projects
Title: Family Violence Prevention and Services: Grants to State;
Native American Tribes and Alaskan Native Villages, and State Domestic
Violence Coalitions.
OMB No.: 0970-0280.
Description: The Family Violence Prevention and Services Act
(FVPSA), 42 U.S.C. 10401 et seq., authorizes the Department of Health
and Human Services to award grants to States, Tribes--and Tribal
Organizations, and State Domestic Violence Coalitions for family
violence prevention and intervention activities. The proposed
information collection activities will be used to make grant award
decisions and to monitor grant performance.
Respondents
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per burden hours Total burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
State Grant Application......................... 53 1 10 530
Tribal Grant Application........................ 200 1 5 1,000
State Domestic Violence Coalition Application... 56 1 10 560
State FVPSA Grant Performance Progress Report... 53 1 10 530
Tribal FVPSA Grant Performance Progress Report.. 200 1 10 2,000
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 4,620
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011-5181 Filed 3-7-11; 8:45 am]
BILLING CODE 4184-01-P
